scholarly article | Q13442814 |
P50 | author | Alan W Stitt | Q63865513 |
P2093 | author name string | He C | |
Vlassara H | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 549-556 | |
P577 | publication date | 1999-03-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells | |
P478 | volume | 256 |
Q33727690 | AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease |
Q35067948 | Advanced glycation endproducts and osteoarthritis |
Q28365776 | Advanced glycation: an important pathological event in diabetic and age related ocular disease |
Q73980634 | Age-related changes in cells and tissues due to advanced glycation end products (AGEs) |
Q28362386 | Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells |
Q40558928 | Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products |
Q48580864 | Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations |
Q44650505 | Cellular Carbonyl Stress Enhances the Expression of Plasminogen Activator Inhibitor-1 in Rat White Adipocytes via Reactive Oxygen Species-dependent Pathway |
Q37089750 | Cellular signaling and potential new treatment targets in diabetic retinopathy |
Q40477757 | Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium |
Q90720617 | Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products |
Q35087841 | Diabetic complications and dysregulated innate immunity |
Q37733102 | Dietary hyperglycemia, glycemic index and metabolic retinal diseases |
Q45151232 | Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products |
Q35168430 | Endothelins in chronic diabetic complications. |
Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
Q35842591 | Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes |
Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
Q53510307 | Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction. |
Q39700115 | Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. |
Q33186938 | Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products |
Q73040201 | Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins |
Q38330759 | Mechanisms of distal axonal degeneration in peripheral neuropathies. |
Q41997847 | Neurodegenerative diseases of the retina and potential for protection and recovery |
Q34103169 | Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy |
Q34470639 | The AGE-receptor in the pathogenesis of diabetic complications |
Q30317876 | The effect of an AGE-rich dietary extract on the activation of NF-κB depends on the cell model used. |
Q24602544 | The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas |
Q34436018 | The maillard reaction in eye diseases |
Q35166467 | The role of advanced glycation in the pathogenesis of diabetic retinopathy. |
Q34090982 | Therapeutic potential of endothelin receptor antagonists in diabetes |
Q35553234 | Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3. |
Q36245387 | Understanding RAGE, the receptor for advanced glycation end products |
Q28081090 | Vascular Effects of Dietary Advanced Glycation End Products |
Q37636453 | Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms |
Q37202605 | Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats |
Q81393241 | [Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases] |
Search more.